# The Evaluation of Vitiligous Lesions Repigmentation After Topical Administration of Methotrexate in Patients With Active Vitiligo

> **NCT04942860** · PHASE3 · COMPLETED · sponsor: **Nicolaus Copernicus University** · enrollment: 25 (actual)

## Conditions studied

- Non-segmental Vitiligo

## Interventions

- **DRUG:** 1% Methotrexate gel
- **DRUG:** 0.5% Methotrexate gel

## Key facts

- **NCT ID:** NCT04942860
- **Lead sponsor:** Nicolaus Copernicus University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-01
- **Primary completion:** 2023-06-01
- **Final completion:** 2023-08-31
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2023-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04942860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04942860, "The Evaluation of Vitiligous Lesions Repigmentation After Topical Administration of Methotrexate in Patients With Active Vitiligo". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04942860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*